| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8836722 | Surgery | 2018 | 7 Pages |
Abstract
Inhibition of receptor-interacting protein kinase 1 by necrostatin-1 decreases systemic and pulmonary inflammation, decreases lung injury, and increases survival in neonatal mice with sepsis. Targeting the necroptosis pathway might represent a new therapeutic strategy for neonatal sepsis.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Alexandra C. MD, Weng-Lang PhD, Laura W. MD, Naomi-Liza MD, Jeffrey M. MD, Gene F. MD, Ping MD,